Taipei Veterans General Hospital Department of Oncology

:::

姜乃榕 (Nai-Jung Chiang)

Appointment

[Profile]

Career and Experience
Experiences：
Medical Expertise
1. medical oncology, the diagnosis and treatment of gastrointestinal malignancies (esophageal cancer, gastric cancer
2. colorectal cancer, biliary tract cancer and pancreatic cancer) and neuroendocrine tumor/carcinoma
3. the design and implementation of clinical trials
License

Internal Medicine, Medical Oncology, Taiwan Academy of Hospice Palliative Medicine, Hematology
Language Expertise

Mandarin, English, Taiwanese

[Publications]

1. Gopinathan P*, Liu CH*, Chiang NJ*, Huang CJ, Tu HC, Hung SC, Shan YS, Lee GB. Exfoliated tumor cells in bile as a promising indicator of disease status in cholangiocarcinoma. Sensors and Actuators B: Chemical. 346: 130526, 2021. (*Co-first author)

2. Chang KY, Chiang NJ, Wu SY, Yen CJ, Chen SH, Yeh YM, Li CF, Feng X, Wu Katherine, Amanda Johnston, John S Bomalaski, Wu BW, Gao J, Sumit K Subudhi, Ahmed O Kaseb, Jorge M Blando, Shalini S Yadav, Peter W Szlosarek, Chen LT. Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers. Oncoimmunology. 12;10(1):1943253, 2021.

3. Chiang NJ, Chen LT, Shan YS, Yeh CN, Chen MH. Development of Possible Next Line of Systemic Therapies for Gemcitabine-Resistant Biliary Tract Cancers: A Perspective from Clinical Trials. Biomolecules. 13;11(1):97, 2021.

4. Shiah HS*, Chiang NJ*, Lin CC, Yen CJ, Tsai HJ, Wu SY, Su WC, Chang KY, Wang CC, Chang JY, Chen LT. Phase I dose escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors. The Oncologist. doi:10.1002/onco.13612, 2020. Online ahead of print. (*Co-first author)

5. Gopinathan P*, Chiang NJ*, Wang CH, Sinha A, Tsai YC, Tu HC, Hung SC; Hsu PH, Shan YS, Lee GB. Aptamer probed isolation of circulating tumor cells in cholangiocarcinoma patients. Sensors and Actuators B: Chemical. 322: 128569, 2020. (*Co-first author)

6. Chiang NJ, Chen MH, Yang SH, Hsu C, Yen CJ, Tsou HH, Su YY, Chen JS, Shan YS, Chen LT. Multicentre, Phase II Study of Gemcitabine and S-1 in Patients With Advanced Biliary Tract Cancer: TG1308 Study. Liver Int. 40(10):2535-2543, 2020.

7. Chiang NJ, Tsai KK, Chen JS, Yang SH, Hsiao HH, Shan YS, Chen LT. A Multicenter, Phase I/II Trial of Biweekly S-1, Leucovorin, Oxaliplatin and Gemcitabine in Metastatic Pancreatic Adenocarcinoma -TCOG T1211 Study. European Journal of Cancer. 124: 123-130, 2020.

8. Gopinathan P*, Chiang NJ*, Bandaru A, Sinha A, Huang WY, Hung SC, Shan YS, Lee GB. Exploring Circulating Tumor Cells in Cholangiocarcinoma Using a Novel Glycosaminoglycan Probe on a Microfluidic Platform. Adv Healthc Mater. 9(10):e1901875, doi: 10.1002/adhm.201901875, 2020. (*Co-first author)

9. Su YY*, Chiang NJ*, Tsai HJ, Yen CJ, Shan YS, Chen LT. The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort. Sci Rep 10(1):7420, 2020. (*Co-first author)